Retinal neural dysfunction in diabetes revealed with handheld chromatic pupillometry.
diabetes
diabetic retinopathy
melanopsin
photoreceptors
pupillometry
retinal degenerations
Journal
Clinical & experimental ophthalmology
ISSN: 1442-9071
Titre abrégé: Clin Exp Ophthalmol
Pays: Australia
ID NLM: 100896531
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
17
05
2022
received:
13
01
2022
accepted:
20
05
2022
pubmed:
27
5
2022
medline:
15
10
2022
entrez:
26
5
2022
Statut:
ppublish
Résumé
To evaluate the ability of handheld chromatic pupillometry to reveal and localise retinal neural dysfunction in diabetic patients with and without diabetic retinopathy (DR). This cross-sectional study included 82 diabetics (DM) and 93 controls (60.4 ± 8.4 years, 44.1% males). DM patients included those without (n = 25, 64.7 ± 6.3 years, 44.0% males) and with DR (n = 57, 60.3 ± 8.5 years, 64.9% males). Changes in horizontal pupil radius in response to blue (469 nm) and red (640 nm) light stimuli were assessed monocularly, in clinics, using a custom-built handheld pupillometer. Pupillometric parameters (phasic constriction amplitudes [predominantly from the outer retina], maximal constriction amplitudes [from the inner and outer retina] and post-illumination pupillary responses [PIPRs; predominantly from the inner retina]) were extracted from baseline-adjusted pupillary light response traces and compared between controls, DM without DR, and DR. Net PIPR was defined as the difference between blue and red PIPRs. Phasic constriction amplitudes to blue and red lights were decreased in DR compared to controls (p < 0.001; p < 0.001). Maximal constriction amplitudes to blue and red lights were decreased in DR compared to DM without DR (p < 0.001; p = 0.02), and in DM without DR compared to controls (p < 0.001; p = 0.005). Net PIPR was decreased in both DR and DM without DR compared to controls (p = 0.02; p = 0.03), suggesting a wavelength-dependent (and hence retinal) pupillometric dysfunction in diabetic patients with or without DR. Handheld chromatic pupillometry can reveal retinal neural dysfunction in diabetes, even without DR. Patients with DM but no DR displayed primarily inner retinal dysfunction, while patients with DR showed both inner and outer retinal dysfunction.
Sections du résumé
BACKGROUND
To evaluate the ability of handheld chromatic pupillometry to reveal and localise retinal neural dysfunction in diabetic patients with and without diabetic retinopathy (DR).
METHODS
This cross-sectional study included 82 diabetics (DM) and 93 controls (60.4 ± 8.4 years, 44.1% males). DM patients included those without (n = 25, 64.7 ± 6.3 years, 44.0% males) and with DR (n = 57, 60.3 ± 8.5 years, 64.9% males). Changes in horizontal pupil radius in response to blue (469 nm) and red (640 nm) light stimuli were assessed monocularly, in clinics, using a custom-built handheld pupillometer. Pupillometric parameters (phasic constriction amplitudes [predominantly from the outer retina], maximal constriction amplitudes [from the inner and outer retina] and post-illumination pupillary responses [PIPRs; predominantly from the inner retina]) were extracted from baseline-adjusted pupillary light response traces and compared between controls, DM without DR, and DR. Net PIPR was defined as the difference between blue and red PIPRs.
RESULTS
Phasic constriction amplitudes to blue and red lights were decreased in DR compared to controls (p < 0.001; p < 0.001). Maximal constriction amplitudes to blue and red lights were decreased in DR compared to DM without DR (p < 0.001; p = 0.02), and in DM without DR compared to controls (p < 0.001; p = 0.005). Net PIPR was decreased in both DR and DM without DR compared to controls (p = 0.02; p = 0.03), suggesting a wavelength-dependent (and hence retinal) pupillometric dysfunction in diabetic patients with or without DR.
CONCLUSIONS
Handheld chromatic pupillometry can reveal retinal neural dysfunction in diabetes, even without DR. Patients with DM but no DR displayed primarily inner retinal dysfunction, while patients with DR showed both inner and outer retinal dysfunction.
Identifiants
pubmed: 35616273
doi: 10.1111/ceo.14116
pmc: PMC9796882
doi:
Substances chimiques
Rod Opsins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
745-756Informations de copyright
© 2022 The Authors. Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists.
Références
Acta Ophthalmol. 2022 Sep;100(6):713-715
pubmed: 34411454
Optom Vis Sci. 2014 Aug;91(8):894-903
pubmed: 24879087
Proc Biol Sci. 2013 Apr 03;280(1759):20122987
pubmed: 23554393
Clin Ophthalmol. 2020 Nov 17;14:3923-3930
pubmed: 33244218
JAMA Ophthalmol. 2019 Oct 01;137(10):1125-1132
pubmed: 31343674
J Clin Med. 2021 Jan 25;10(3):
pubmed: 33504108
J Neurosci. 2012 Oct 10;32(41):14242-53
pubmed: 23055493
PLoS One. 2015 May 12;10(5):e0125919
pubmed: 25965421
Acta Ophthalmol. 2012 May;90(3):e230-4
pubmed: 21883986
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):1870-1878
pubmed: 31042793
Br J Ophthalmol. 2022 Apr;106(4):528-533
pubmed: 33293271
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Sci Rep. 2018 Apr 4;8(1):5636
pubmed: 29618794
Arch Ophthalmol. 1985 Jan;103(1):51-4
pubmed: 3977675
Diabetes Care. 2019 Apr;42(4):529-538
pubmed: 30796110
Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2187-2192
pubmed: 28399269
PLoS One. 2014 Jul 09;9(7):e101584
pubmed: 25006976
Invest Ophthalmol Vis Sci. 2004 Mar;45(3):948-54
pubmed: 14985316
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Arq Bras Oftalmol. 2021 Jan-Feb;84(1):37-44
pubmed: 33470340
Vision Res. 2010 Jan;50(1):72-87
pubmed: 19850061
Nature. 2008 May 1;453(7191):102-5
pubmed: 18432195
Ophthalmology. 2018 Sep;125(9):1362-1371
pubmed: 29573814
Acta Diabetol. 2021 Sep;58(9):1201-1208
pubmed: 33851274
Ophthalmology. 2015 Sep;122(9):1777-85
pubmed: 26299721
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2655-64
pubmed: 27114552
Ophthalmic Res. 2016;56(1):1-9
pubmed: 27035578
Prog Retin Eye Res. 2006 Sep;25(5):425-48
pubmed: 16949855
Sci Rep. 2020 Jan 31;10(1):1560
pubmed: 32005914
Br J Ophthalmol. 2021 Dec 1;:
pubmed: 34853018
Vision Res. 2017 Oct;139:101-107
pubmed: 28408138
Sci Rep. 2017 Mar 23;7:44987
pubmed: 28332564
Transl Vis Sci Technol. 2014 Jun 19;3(3):6
pubmed: 24959388
Diabetes. 2021 May;70(5):1157-1169
pubmed: 33574020
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Clin Exp Ophthalmol. 2022 Sep;50(7):745-756
pubmed: 35616273
Neuroophthalmology. 2019 Nov 25;44(4):226-235
pubmed: 33012908
Ophthalmology. 2004 Nov;111(11):2133-6
pubmed: 15522382
Acta Ophthalmol. 2020 Jan 13;:
pubmed: 31943805
Invest Ophthalmol Vis Sci. 2013 Feb 15;54(2):1370-7
pubmed: 23372054
Arch Ophthalmol. 1998 Oct;116(10):1316-20
pubmed: 9790629
Arch Ophthalmol. 2004 Dec;122(12):1809-15
pubmed: 15596584
Doc Ophthalmol. 1989 Oct;73(2):193-200
pubmed: 2638628
JAMA Ophthalmol. 2019 Oct 1;137(10):1132-1133
pubmed: 31343699
Int Ophthalmol. 2020 Nov;40(11):3127-3134
pubmed: 32623631